TY - JOUR
T1 - PH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery
AU - Mukhopadhyay, Piyasi
AU - Chakraborty, Souma
AU - Bhattacharya, Sourav
AU - Mishra, Roshnara
AU - Kundu, P. P.
N1 - Publisher Copyright:
© 2014 Elsevier B.V.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Chitosan-alginate (CS/ALG) nanoparticles were prepared by formation of an ionotropic pre-gelation of an alginate (ALG) core entrapping insulin, followed by chitosan (CS) polyelectrolyte complexation, for successful oral insulin administration. Mild preparation process without harsh chemicals is aimed at improving insulin bio-efficiency in in vivo model. The nanoparticles showed an average particle size of 100-200. nm in dynamic light scattering (DLS), with almost spherical or sub-spherical shape and ~85% of insulin encapsulation. Again, retention of almost entire amount of encapsulated insulin in simulated gastric buffer followed by its sustained release in simulated intestinal condition proved its pH sensitivity in in vitro release studies. Significant hypoglycemic effects with improved insulin-relative bioavailability (~8.11%) in in vivo model revealed the efficacy of these core-shell nanoparticles of CS/ALG as an oral insulin carrier. No systemic toxicity was found after its peroral treatment, suggesting these core-shell nanoparticles as a promising device for potential oral insulin delivery.
AB - Chitosan-alginate (CS/ALG) nanoparticles were prepared by formation of an ionotropic pre-gelation of an alginate (ALG) core entrapping insulin, followed by chitosan (CS) polyelectrolyte complexation, for successful oral insulin administration. Mild preparation process without harsh chemicals is aimed at improving insulin bio-efficiency in in vivo model. The nanoparticles showed an average particle size of 100-200. nm in dynamic light scattering (DLS), with almost spherical or sub-spherical shape and ~85% of insulin encapsulation. Again, retention of almost entire amount of encapsulated insulin in simulated gastric buffer followed by its sustained release in simulated intestinal condition proved its pH sensitivity in in vitro release studies. Significant hypoglycemic effects with improved insulin-relative bioavailability (~8.11%) in in vivo model revealed the efficacy of these core-shell nanoparticles of CS/ALG as an oral insulin carrier. No systemic toxicity was found after its peroral treatment, suggesting these core-shell nanoparticles as a promising device for potential oral insulin delivery.
KW - Bioavailability
KW - Chitosan/alginate pH-sensitive nanoparticles
KW - Oral insulin delivery
UR - https://www.scopus.com/pages/publications/84907841776
U2 - 10.1016/j.ijbiomac.2014.08.040
DO - 10.1016/j.ijbiomac.2014.08.040
M3 - Article
C2 - 25239194
AN - SCOPUS:84907841776
SN - 0141-8130
VL - 72
SP - 640
EP - 648
JO - International Journal of Biological Macromolecules
JF - International Journal of Biological Macromolecules
ER -